Danazol treatment of endometriosis: long-term follow-up
OA: closed
CC0
AI-generated summary
This study reports on the long-term outcomes of danazol treatment for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (18)
- Antigonadotropin (danazol) in the treatment of endometriosis. Evaluation of posttreatment fertility and three-year follow-up data via openalex
- Clinical studies with an antigonadotropin-Danazol via openalex
- Danazol--a synthetic steroid derivative with interesting physiologic properties via openalex
- Effects of progestin-induced pseudopregnancy on endometriosis: clinical and microscopic studies via openalex
- ENDOMETRIOSIS AND INFERTILITY via openalex
- Experiences with Danazol (an antigonadotropin) in the treatment of infertility via openalex
- Infertility with endometriosis. A plan of therapy via openalex
- Influence of Danazol (100 mg) on conception and contraception via openalex
- Letter: How does danazol work? via openalex
- Pituitary gonadotropin inhibitory activity of danazol via openalex
- Recent advances in endometriosis via openalex
- Surgical management of endometriosis via openalex
- The treatment of endometriosis with Danazol via openalex
- The use of newer progestins in the treatment of endometriosis via openalex
- The use of stilbestrol for endometriosis; preliminary report via openalex
- W258752081 via openalex
- W122652578 via openalex
- W6660370477 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK